At this year’s Medtrade Fall, which took place Oct 31-Nov 3, Philips Respironics, showcased its portfolio of integrated connected care software, solutions, and services that aim to provide greater value to durable medical equipment (DME) providers and increase patient adherence to therapy. Philips also hosted its first Fall Forum, aiming to engage industry leaders in discussions around the sleep and respiratory markets’ biggest challenges and opportunities.

Philips showcased its Patient Adherence Management Services (PAMS) care management service. Developed with input from a behavioral scientist and designed for homecare providers looking for additional support in helping to improve sleep patient adherence, Philips’ PAMS has been shown to boost CPAP therapy adherence rates by 49% on average.1 PAMS utilizes Philips Respironics EncoreAnywhere software, a compliance management platform. PAMS is expected to reach the milestone of 200,000 lives managed through the service in mid-November.

“By developing connected health solutions, we’ve made it possible for physicians and home medical equipment (HME) providers to have more comprehensive insight into therapy use and efficacy. This allows them to adjust therapeutic settings or intervene to help patients be successful in therapy longer. We use this same technology to drive PAMS,” says Jim Doty, the senior field marketing director at Philips Respironics, in a release. “Through innovative connected platforms, including our recently introduced Care Orchestrator clinical management solution, we aim to achieve a transformative impact on the homecare industry similar to the impact EncoreAnywhere had 10 years ago as the first cloud based patient management system.”

During the show, beyond PAMS, attendees saw innovations including:

  • Care Orchestrator: Care Orchestrator will connect with Philips sleep and respiratory devices and other relevant patient data, including billing and insurance information and electronic health records;
  • SimplyGo Mini: The smallest and lightest POC in the Philips portfolio;
  • Trilogy ventilator with AVAPS-AE: The most widely dispensed ventilator for home use in United States,2 designed to meet the needs of the respiratory failure patient with enhanced comfort and synchrony in breathing; and
  • Sleep therapy solutions, including: The Dream Family OSA products, Amara View mask, and the new Wisp Pediatric Nasal mask.

References

1. Retrospective study using 2014 -2016 EncoreAnywhere data from 12 Home Care Providers that used PAMS for at least six months. CMS Compliance definition – minimum of 4 hours of use over 70% of the nights during a consecutive 30 day period within the first 90 days of use.

2. Philips–sponsored market survey study of 120 DMEs on the brands of ventilators the DMEs set-up for patients in May 2016.